CERVICAL CANCER AND HUMAN PAPILLOMAVIRUS
Grce M*
*Corresponding Author: Dr. sc. Magdalena Grce, Rudjer Boskovic Institute, Laboratory of Molecular Virology and Bacteriology, Division of Molecular Medicine, Bijenicka 54, HR-10002 Zagreb, Croatia; Tel.: +385-1-4561110; Fax: +385-1-4561010; E-mail: grce@irb.hr
page: 19

REFERENCES

1. IARC (International Agency for Research on Can­cer). Monograph on the evaluation of carcinogenic risks to humans, Vol 64. Human papillomaviruses. Lyon: IARC, 1995.

2. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: cancer incidence, mortality and prevalence world­wide. IARC Cancer Base No. 5. Version 2.0. Lyon: IARC Press, 2004.

3. Bethesda Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis: report of the National Cancer Institute, Bethesda. JAMA 1989; 262(7): 931-934.

4. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Topics Microbiol Immunol 1994; 186: 1-12.

5. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12-19.

6. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 384(6): 518 -527.


7. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 1995; 69(5): 3074-3083.

8. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillo­mavirus and cervical cancer. J Clin Pathol 2002; 55(4): 244-265.

9. Grce M, Husnjak K, Bozikov J, Zlacki M, Lukac J, Fistonic I, Magdic L, Skrablin S, Sikanic-Dugic N, Pavelic K. Cervical human papillomavirus (HPV) infec­tions in Croatia. Anticancer Res 2001; 21(1B): 579-584.

10. Clifford GM, Smith, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervi­cal lesions and cervical cancer: a meta-analysis. Br J Can­cer 2003; 89(1): 101-105.

11. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillo­mavirus types. Curr Topics Microbiol Immunol 1994; 186: 131-155.

12. Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer 1997; 33(5): 781-786.

13. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S; Interna­tional Agency for Research on Cancer. Multicentric Cer­vical Cancer Study Group. Effect of oral contraceptives on risk of cervical cancer in women with human papillo­mavirus infection: the IARC multicentric case-control study. The Lancet 2002; 359(9312): 1085-1092.

14. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V. Cervical cancer and use of hormonal contraceptives: a systematic review. The Lancet 2003; 361(9364): 1159-1167.

15. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003; 14(9): 805-814.

16. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S, IARC Multicenter Cervical Cancer Study Group. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346(15): 1105-1112.

17. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82(6): 454-461.

18. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995; 141(7): 680-689.

19. Sherman ME. Future directions in cervical pathol­ogy. J Natl Cancer Inst Monogr 2003; 31: 72-79.


20. Cuzick J. Role of HPV testing in clinical practice. Virus Res 2002; 89(2): 263-269.

21. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright TC Jr, Kinney W, Meijer CJ, Linder J, McGoogan E, Meijer C. Cervical cancer control, priorities and new directions. Int J Cancer 2004; 108(3): 329-333.

22. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, for the 2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus guidelines for the manage­ment of women with cervical cytological abnormalities. JAMA 2002; 287(16): 2120-2129.

23. Ljubojevic N, Babic S, Audy-Jurkovic S, Ovanin-Rakic A, Jukic S, Babic D, Grubisic G, Radakovic B, Ljubojevic-Grgec D. Improved national Croatian diagnos­tic and therapeutic guidelines for premalignant lesions of the uterine cervix with some cost-benefit aspects. Coll Antropol 2001; 25(2): 467-474.

24. Husnjak K, Grce M, Magdic L, Pavelic K. Com­parison of five different polymerase chain reaction (PCR) methods for detection of human papillomavirus (HPV) in cervical cell specimens. J Virol Methods 2000; 88(2): 125-134.

25. Iftner T, Villa LL. Human papillomavirus technol­ogies. J Natl Cancer Inst Monogr 2003; 31: 80-88.

26. Cohen S. Beyond slogans: lessons from Uganda’s experience with ABC and HIV/AIDS. Reprod Health Matters 2004; 12(23): 132-135.

27. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vac­cine. N Engl J Med 2002; 347(21): 1645-1651.




Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006